Showing 2821-2830 of 4162 results for "".
- Alastin Skincare Introduces TransFORM Body Treatment at ASDS Meetinghttps://modernaesthetics.com/news/alastin-skincare-introduces-transform-body-treatment-at-asds-meeting/2472018/
- Evolus Resubmits BLA for DWP-450 Ahead of Schedulehttps://modernaesthetics.com/news/evolus-resubmits-bla-for-dwp-450-ahead-of-schedule/2472049/Evolus has resubmitted its Biologics License Application (BLA) for its lead product candidate, DWP-450 (prabotulinumtoxinA), to the FDA. The resubmission follows the receipt of a Complete Response Letter (“CRL”) from the FDA in May 2018 which necessita
- BTL Geared to Share New Research, Latest Innovation at American Society for Laser Medicine & Surgery Annual Conferencehttps://modernaesthetics.com/news/btl-geared-to-share-new-research-latest-innovation-at-american-society-for-laser-medicine-surgery-annual-conference/2472110/
- Case Report Describes Dual-Phase CL Code for Facial Rejuvenationhttps://modernaesthetics.com/news/case-report-describes-dual-phase-cl-code-for-facial-rejuvenation/2486484/A case report in the April 2026 issue of Journal of Cosmetic Dermatology described a dual-phase injectable approach to facial rejuvenation that combined contour restoration with ligamentous support using a polycaprolactone-based collagen stimulator. The authors termed the method the “CL
- AAD 2026: Acclaro to Highlight Expanding Clinical Uses of UltraClear 2910 nm Fiber Laserhttps://modernaesthetics.com/news/aad-2026-acclaro-to-highlight-expanding-clinical-uses-of-ultraclear-2910-nm-fiber-laser/2486381/Emerging clinical data on Acclaro’s UltraClear® 2910 nm fiber laser is set to be presented during multiple sessions at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado from March 26 through 31. The technology, a cold ablative fiber lase
- Revance, Teoxane Introduce RHA® Dynamic Volume for Facial Rejuvenationhttps://modernaesthetics.com/news/revance-teoxane-introduce-rha-dynamic-volume-for-facial-rejuvenation/2486353/Revance and Teoxane have announced the availability of RHA® Dynamic Volume, formerly known as RHA® 4 Mepi, expanding the RHA® Collection with a hyaluronic acid filler designed to adapt to facial movement and support natural-looking outcomes. The product has been approved by the US Food and Drug A
- Allergan Aesthetics Panel: Medical Weight Loss Fuels New Aesthetic Conversationshttps://modernaesthetics.com/news/allergan-aesthetics-panel-medical-weight-loss-fuels-new-aesthetic-conversations/2485952/Experts at Allergan Aesthetics’ “Navigating the New Era of Patient Needs” virtual event highlighted how GLP-1 receptor agonists (GLP-1 RAs) are changing facial aesthetic concerns, patient education, and treatment sequencing. Th
- Internal Mammary Vessels Lead in Autologous Breast Reconstruction, Review Findshttps://modernaesthetics.com/news/internal-mammary-vessels-lead-in-autologous-breast-reconstruction-review-finds/2485836/Autologous breast reconstruction most commonly relies on free tissue transfer to achieve natural-appearing and aesthetically favorable outcomes. In a narrative review published in Gland Surgery, the authors examined recipient vessel selection strategies and their clinical implications in
- Photocurable Collagen Filler Aims to Address Weight-Loss–Associated Facial Deflationhttps://modernaesthetics.com/news/photocurable-collagen-filler-aims-to-address-weight-lossassociated-facial-deflation/2485851/CollPlant Biotechnologies announced the strategic positioning of its photocurable dermal filler platform to address facial volume loss associated with rapid weight reduction, including in patients treated with glucagon-like peptide-1 receptor agonists (GLP-1 RA) for metabolic health and weight ma
- The Rise of Biostimulators: Complement, Not Competitor, in Aesthetic Regimenshttps://modernaesthetics.com/news/the-rise-of-biostimulators-complement-not-competitor-in-aesthetic-regimens/2485824/The filler category of medical aesthetics may have faced certain headwinds in 2025, but biostimulatory agents experienced a noticeable uptick. Still, at the 2026 Octane Aesthetics Tech Forum, “Flipping the Filler Script” panelists cautioned against viewing them as a replacement for hyaluronic aci